The morphogenic properties of oligomeric endostatin are dependent on cell surface heparan sulfate.
AuthorsClamp, Andrew R
Blackhall, Fiona H
Jayson, Gordon C
Esko, Jeffrey D
Gallagher, John T
Merry, Catherine L R
AffiliationDepartment of Medical Oncology, Cancer Research UK and the University of Manchester, Christie Hospital NHS Trust, Manchester M20 4BX, United Kingdom.
MetadataShow full item record
AbstractEndostatin has attracted considerable attention because of its ability to inhibit angiogenesis. This property of monomeric endostatin contrasts with that of the trimeric endostatin moiety generated from the intact C-terminal domain of collagen XVIII that induces a promigratory phenotype in endothelial cells. This activity is inhibited by monomeric endostatin. In this study we demonstrate that the effect of oligomeric endostatin can also be inhibited by exogenous glycosaminoglycans in a size-dependent manner, with heparin oligosaccharides containing more than 20 monosaccharide residues having optimal inhibitory activity. Oligomeric endostatin was also found to induce morphological changes in Chinese hamster ovary cells, an epithelial cell line. This novel observation allowed the utilization of a panel of Chinese hamster ovary cell mutants with defined glycosaminoglycan biosynthetic defects. The action of oligomeric endostatin on these cells was shown to be dependent on cell surface glycosaminoglycans, principally heparan sulfate with N- and 6-O-sulfation of glucosamine residues rather than iduronate 2-O-sulfation being important for bioactivity. The responsiveness of a cell line (pgsE-606) with globally reduced heparan sulfate sulfation and shortened S domains, however, indicates that overall heparan sulfate domain patterning is the key determinant of the bioactivity of oligomeric endostatin. Purified heparin-monomeric endostatin constructs generated by zero-length cross-linking techniques were found to be unable to inhibit the action of oligomeric endostatin. This indicates a mechanism for the perturbation of oligomeric endostatin action by its monomeric counterpart via competition for glycosaminoglycan attachment sites at the cell surface.
CitationThe morphogenic properties of oligomeric endostatin are dependent on cell surface heparan sulfate. 2006, 281 (21):14813-22 J. Biol. Chem.
JournalThe Journal of Biological Chemistry
- Molecular interplay between endostatin, integrins, and heparan sulfate.
- Authors: Faye C, Moreau C, Chautard E, Jetne R, Fukai N, Ruggiero F, Humphries MJ, Olsen BR, Ricard-Blum S
- Issue date: 2009 Aug 14
- Characterization of endostatin binding to heparin and heparan sulfate by surface plasmon resonance and molecular modeling: role of divalent cations.
- Authors: Ricard-Blum S, Féraud O, Lortat-Jacob H, Rencurosi A, Fukai N, Dkhissi F, Vittet D, Imberty A, Olsen BR, van der Rest M
- Issue date: 2004 Jan 23
- Detection of 2-O-sulfated iduronate and N-acetylglucosamine units in heparan sulfate by an antibody selected against acharan sulfate (IdoA2S-GlcNAc)n.
- Authors: ten Dam GB, van de Westerlo EM, Smetsers TF, Willemse M, van Muijen GN, Merry CL, Gallagher JT, Kim YS, van Kuppevelt TH
- Issue date: 2004 Sep 10
- Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin.
- Authors: Sasaki T, Larsson H, Kreuger J, Salmivirta M, Claesson-Welsh L, Lindahl U, Hohenester E, Timpl R
- Issue date: 1999 Nov 15
- Non-heparan sulfate-binding interactions of endostatin/collagen XVIII in murine development.
- Authors: Rychkova N, Stahl S, Gaetzner S, Felbor U
- Issue date: 2005 Feb